Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib.
about
Evaluation of elastix-based propagated align algorithm for VOI- and voxel-based analysis of longitudinal (18)F-FDG PET/CT data from patients with non-small cell lung cancer (NSCLC)Total Body Metabolic Tumor Response in ALK Positive Non-Small Cell Lung Cancer Patients Treated with ALK Inhibition.Association Between (18)F-FDG Avidity and the BRAF Mutation in Papillary Thyroid Carcinoma.Image-derived biomarkers and multimodal imaging strategies for lung cancer management.Early Change in FDG-PET Signal and Plasma Cell-Free DNA Level Predicts Erlotinib Response in EGFR Wild-Type NSCLC Patients.Prognostic value of metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinomaDual-Phase Dual-Energy CT in Patients Treated with Erlotinib for Advanced Non-Small Cell Lung Cancer: Possible Benefits of Iodine Quantification in Response Assessment.Assessment of very early response evaluation with 18F-FDG-PET/CT predicts survival in erlotinib treated NSCLC patients-A comparison of methods.CEA serum level as early predictive marker of outcome during EGFR-TKI therapy in advanced NSCLC patients.
P2860
Q30926992-1DD67C37-C14B-45CB-9A27-001126EFCED6Q36006242-B5F55E86-FFE4-46DC-8874-D25C16979CCCQ36604985-949DF8E8-2CBB-4422-964A-4C8B8CF41C38Q38312373-BEBEBA73-EB25-4054-B441-7D2950E7D8CDQ40418227-A8FCC845-B462-46C3-A86A-32FF9B265322Q41622132-7A53ED81-4AAA-4885-BEE0-E49E3E925693Q52902982-E1CA4B4B-3327-4AB4-A41E-7491C8FD68D7Q54965644-984AFCC0-5388-4D51-B659-CCCBFF39B7E2Q55066534-A376CCB2-F8A7-4B69-82C4-6659EB1E77A7
P2860
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Predictive and prognostic valu ...... tients treated with erlotinib.
@en
Predictive and prognostic valu ...... tients treated with erlotinib.
@nl
type
label
Predictive and prognostic valu ...... tients treated with erlotinib.
@en
Predictive and prognostic valu ...... tients treated with erlotinib.
@nl
prefLabel
Predictive and prognostic valu ...... tients treated with erlotinib.
@en
Predictive and prognostic valu ...... tients treated with erlotinib.
@nl
P2093
P2860
P50
P1476
Predictive and prognostic valu ...... atients treated with erlotinib
@en
P2093
Andrea Ardizzoni
Beatrice Bortesi
Claudia Fumarola
Fiorenza Latteri
Hector J Soto Parra
Marco Bartolotti
Massimo Ippolito
Maura Scarlattei
Pier Giorgio Petronini
Pietro Spadaro
P2860
P2888
P304
P356
10.1007/S00280-013-2356-X
P577
2013-11-21T00:00:00Z
P5875
P6179
1013277061